Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rite Aid Corp (NY: RAD )

2.150 +0.040 (+1.90%)
Official Closing Price Updated: 7:00 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rite Aid Corp

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - RAD
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
RITE AID CORPORATION (NYSE: RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Rite Aid Corporation (NYSE: RAD)
From Bernstein Liebhard LLP
Via Globe NewsWire
Top 5 Defensive Stocks That Are Set To Fly
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 479 stocks made new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 469 companies hit new 52-week lows. 
Via Benzinga
Rite Aid to Release Fourth Quarter Results on April 20
From Rite Aid Corporation
Via Business Wire
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Rite Aid Corporation (RAD) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Rite Aid Corporation (RAD) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Rite Aid Corporation Investors – RAD
From The Rosen Law Firm, P.A.
Via Business Wire
RAD EQUITY NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors to Inquire About Securities Class Action Investigation - RAD
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Rite Aid Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rite Aid Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Rite Aid Corporation Investors to Inquire About Securities Class Action Investigation – RAD
From Rosen Law Firm
Via Business Wire
Department of Justice Accuses Rite Aid For Ignoring Obvious Signs Of Opioid Misuse
The U.S. government reportedly sued Rite Aid Corp (NYSE: RAD), saying the company missed "red flags" as it illegally filled prescriptions for controlled substances, including opioids. 
Via Benzinga
New York Governor, Attorney General Ask Three Pharmacy Operators' Commitment Over Abortion Drug Access
 
Via Benzinga
7 Retail Stocks to Skip as Shoppers Pull back on Spending
These are just a few of the top retail stocks to sell, especially with many consumers living paycheck to paycheck. 
Via InvestorPlace
Top 5 Risk Off Stocks That You May Want To Dump In Q1 2023
The most overbought stocks in the consumer staples sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
CVS Health Corporation Is Coiled And Ready To Spring Higher
The price action in CVS Health has been coiling up over the last 15 months and it looks ready to spring higher. 
Via Talk Markets
CVS Health Corporation Is Coiled And Ready To Spring Higher
CVS Health strategy to become a diversified healthcare operator is paying off and the analysts clearly approve. Earnings shine and guidance is good, too. 
Via MarketBeat
Is Amazon the Future of Healthcare?
The e-commerce titan announced the RxPass subscription for Prime members. What companies will this service disrupt, and can Amazon stock benefit? 
Via The Motley Fool
CVS Health is Growing into an Integrated Healthcare Organization
Pharmacy, insurance, and healthcare services provider CVS Health Corporation (NYSE: CVS) shares are trading near 52-week lows despite the recent rally in the 
Via MarketBeat
Exposures COVID-19
Stocks That Hit 52-Week Lows On Friday
  Friday saw 23 companies set new 52-week lows. 
Via Benzinga
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
Here's a round-up of stories from around the globe and from various media outlets. Benzinga 
Via Benzinga
Rite Aid Starts Selling Abortion Medication From Few Pharmacies: Report
Rite Aid Corp (NYSE: RAD) plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 29 stocks made new 52-week lows. 
Via Benzinga
Is Walgreens Boots Alliance Earnings Miss Good For Investors?
Integrated healthcare and pharmacy retailer Walgreens Boots Alliance Inc. (NYSE: WBA) stock recovered some sell-off losses from its fiscal Q1 2023 earnings 
Via MarketBeat
Topics Earnings Lawsuit
Exposures COVID-19 Financial Legal
5 Retail Stocks to Put on Your 2023 Death Watch
Survival for any of these retail stocks to sell would mean big profits for investors who buy now, but that's not the way to bet. 
Via InvestorPlace
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. 
Via Benzinga
Rite Aid Corporation Names Elizabeth “Busy” Burr Interim Chief Executive Officer
From Rite Aid Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.